SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-000410
Filing Date
2021-01-07
Accepted
2021-01-07 08:05:44
Documents
9
Period of Report
2021-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 42280
2 ex5-1.htm EX-5.1 31242
3 ex5-1_01.jpg GRAPHIC 4149
4 ex5-1_02.jpg GRAPHIC 2273
5 ex5-1_03.jpg GRAPHIC 15440
6 ex10-1.htm EX-10.1 207757
7 ex10-2.htm EX-10.2 96587
8 ex99-1.htm EX-99.1 10108
9 ex99-1_001.jpg GRAPHIC 3918
  Complete submission text file 0001493152-21-000410.txt   425198
Mailing Address 711 STEWART AVENUE GARDEN CITY NEW YORK NY 11530
Business Address 711 STEWART AVENUE GARDEN CITY NEW YORK NY 11530 (215) 345-0919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21617 | Film No.: 21513024
SIC: 2834 Pharmaceutical Preparations